Todd C. Brady

910 total citations
21 papers, 721 citations indexed

About

Todd C. Brady is a scholar working on Public Health, Environmental and Occupational Health, Dermatology and Immunology and Allergy. According to data from OpenAlex, Todd C. Brady has authored 21 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Dermatology and 6 papers in Immunology and Allergy. Recurrent topics in Todd C. Brady's work include Ocular Surface and Contact Lens (9 papers), Allergic Rhinitis and Sensitization (6 papers) and Contact Dermatitis and Allergies (4 papers). Todd C. Brady is often cited by papers focused on Ocular Surface and Contact Lens (9 papers), Allergic Rhinitis and Sensitization (6 papers) and Contact Dermatitis and Allergies (4 papers). Todd C. Brady collaborates with scholars based in United States and Sweden. Todd C. Brady's co-authors include Christine M. Havrilla, Ed Levin, Kaela Kelly, James D. Crapo, David L. Clark, John D. Sheppard, Huaxin Sheng, Robert D. Pearlstein, Ling‐Yi Chang and Brian J. Day and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Health Perspectives and Journal of Allergy and Clinical Immunology.

In The Last Decade

Todd C. Brady

20 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd C. Brady United States	11	228	148	103	92	88	21	721
Ekambaram Padmini India	18	256 1.1×	262 1.8×	34 0.3×	79 0.9×	98 1.1×	52	942
Christy Lite India	13	318 1.4×	172 1.2×	43 0.4×	60 0.7×	37 0.4×	15	702
Antonio Planchart United States	16	381 1.7×	319 2.2×	44 0.4×	47 0.5×	73 0.8×	34	948
Hamdy A.A. Aly Egypt	13	363 1.6×	182 1.2×	58 0.6×	68 0.7×	54 0.6×	26	855
Cong Yuan China	23	572 2.5×	330 2.2×	46 0.4×	93 1.0×	70 0.8×	74	1.4k
Manish Mishra India	13	228 1.0×	335 2.3×	46 0.4×	58 0.6×	41 0.5×	23	868
J.H.J. van den Berg Netherlands	16	345 1.5×	183 1.2×	29 0.3×	39 0.4×	64 0.7×	35	922
Cailing Lu China	21	235 1.0×	572 3.9×	88 0.9×	66 0.7×	187 2.1×	61	1.3k
Paolo Cocci Italy	18	264 1.2×	115 0.8×	39 0.4×	83 0.9×	22 0.3×	53	781

Countries citing papers authored by Todd C. Brady

Since Specialization

Citations

This map shows the geographic impact of Todd C. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd C. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd C. Brady more than expected).

Fields of papers citing papers by Todd C. Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd C. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd C. Brady. The network helps show where Todd C. Brady may publish in the future.

Co-authorship network of co-authors of Todd C. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Todd C. Brady. A scholar is included among the top collaborators of Todd C. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd C. Brady. Todd C. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Starr, Christopher E., et al.. (2023). The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis. Clinical ophthalmology. Volume 17. 3867–3875. 3 indexed citations

Salapatek, Anne Marie, et al.. (2023). ADX-629, A Reactive Aldehyde Species (RASP) Inhibitor, Reduced Eosinophilia In Asthmatic Subjects After Bronchial Allergen Challenge (BAC). Journal of Allergy and Clinical Immunology. 151(2). AB70–AB70. 1 indexed citations

Clark, David L., Paul Karpecki, Anne Marie Salapatek, John D. Sheppard, & Todd C. Brady. (2022). Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure. SHILAP Revista de lepidopterología. 11 indexed citations

Gomes, Paul J, et al.. (2022). Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial. Ophthalmology and Therapy. 11(4). 1449–1461. 6 indexed citations

Clark, David L., John D. Sheppard, & Todd C. Brady. (2021). A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics. 37(4). 193–199. 24 indexed citations

McMullin, David, et al.. (2021). A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease. Clinical ophthalmology. Volume 15. 3889–3900. 6 indexed citations

Clark, David L., et al.. (2021). Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial. American Journal of Ophthalmology. 230. 60–67. 18 indexed citations

Clark, David L., Joseph Tauber, John D. Sheppard, & Todd C. Brady. (2021). Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease. American Journal of Ophthalmology. 226. 22–31. 22 indexed citations

Mandell, Kenneth J., David L. Clark, David Chu, et al.. (2020). Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement. Journal of Ocular Pharmacology and Therapeutics. 36(10). 732–739. 16 indexed citations

10.

Halilovic, Adna, et al.. (2018). ADX-103, a Novel Small Molecule Aldehyde Sequestering Agent, Decreases Retinal Edema and Inflammation in a Rat Model of Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 59(9). 198–198. 1 indexed citations

11.

Gomes, Paul J, Todd C. Brady, David Hollander, & David L. Clark. (2018). A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent. Investigative Ophthalmology & Visual Science. 59(9). 5571–5571. 1 indexed citations

12.

Halilovic, Adna, et al.. (2018). Novel Small Molecule Aldehyde Sequestering Agents Demonstrate Broad Therapeutic Potential for Ocular Inflammation. Investigative Ophthalmology & Visual Science. 59(9). 2663–2663. 1 indexed citations

13.

Sheppard, John D., Todd C. Brady, C. Stephen Foster, Kenneth J. Mandell, & Scott L. Young. (2017). A Randomized, Comparator-Controlled Phase 2 Clinical Trial of ADX-102 Ophthalmic Solution in Noninfectious Anterior Uveitis. Investigative Ophthalmology & Visual Science. 58(8). 1231–1231. 4 indexed citations

14.

Gibson, Daniel J., Kenneth J. Mandell, Scott L. Young, & Todd C. Brady. (2015). The Aldehyde Trap NS2 Mitigates Dense Haze in a Rabbit Model of Photorefractive Keratectomy. Investigative Ophthalmology & Visual Science. 56(7). 3931–3931. 1 indexed citations

15.

Sheng, Huaxin, et al.. (1999). Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neuroscience Letters. 267(1). 13–16. 79 indexed citations

16.

Kelly, Kaela, et al.. (1998). Oxidative stress in toxicology: established mammalian and emerging piscine model systems.. Environmental Health Perspectives. 106(7). 375–384. 372 indexed citations

17.

Levin, Edward D., Todd C. Brady, Tim D. Oury, et al.. (1998). Molecular Manipulations of Extracellular Superoxide Dismutase: Functional Importance for Learning. Behavior Genetics. 28(5). 381–390. 55 indexed citations

18.

Kelly, Sue, et al.. (1998). Oxidative Stress in Toxicology: Established Mammalian and Emerging Piscine Model Systems. Environmental Health Perspectives. 106(7). 375–375. 21 indexed citations

19.

Brady, Todd C., et al.. (1998). Isolation, purification, and structural characterization of flunixin glucuronide in the urine of greyhound dogs.. PubMed. 26(4). 294–8. 13 indexed citations

20.

Brady, Todd C., Ling‐Yi Chang, Brian J. Day, & James D. Crapo. (1997). Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 273(5). L1002–L1006. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact